Cargando…
Pharmacological use of a novel scaffold, anomeric N,N-diarylamino tetrahydropyran: molecular similarity search, chemocentric target profiling, and experimental evidence
Rational drug design against a determined target (disease, pathway, or protein) is the main strategy in drug discovery. However, regardless of the main strategy, chemists really wonder how to maximize the utility of their new compounds by drug repositioning them as clinical drug candidates in drug d...
Autores principales: | Venkanna, Arramshetti, Kwon, Oh Wook, Afzal, Sualiha, Jang, Cheongyun, Cho, Kyo Hee, Yadav, Dharmendra K., Kim, Kang, Park, Hyeung-geun, Chun, Kwang-Hoon, Kim, Sun Yeou, Kim, Mi-hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624941/ https://www.ncbi.nlm.nih.gov/pubmed/28970544 http://dx.doi.org/10.1038/s41598-017-12082-3 |
Ejemplares similares
-
Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
por: Jang, Cheongyun, et al.
Publicado: (2018) -
A Chemocentric Approach to the Identification of Cancer Targets
por: Flachner, Beáta, et al.
Publicado: (2012) -
Chemocentric Informatics Analysis: Dexamethasone Versus Combination Therapy for COVID-19
por: Hajjo, Rima, et al.
Publicado: (2020) -
Plausible Pnicogen Bonding of epi-Cinchonidine as a Chiral Scaffold in Catalysis
por: Ullah, Zakir, et al.
Publicado: (2021) -
Anomeric effect
por: Szarek, Walter A, et al.
Publicado: (1979)